By 2050, the American 85 years old and over population will triple. Clinicians and the public
health community need to develop a culture of sensitivity to the needs of this population and …

Background In response to the COVID-19 pandemic, the UK first adopted physical
distancing measures in March, 2020. Vaccines against SARS-CoV-2 became available in …

The contribution of influenza B to the seasonal influenza burden varies from year-to-year.
Although 2 antigenically distinct influenza B virus lineages have co-circulated since 2001 …

Background: Cardiovascular mortality is decreasing but remains the leading cause of death
world-wide. Respiratory infections such as influenza significantly contribute to morbidity and …

Background: Seasonal influenza can cause a significant public health burden. Vaccination
is proposed as the most effective measure to prevent influenza and related undesired …

Influenza vaccination can benefit most populations, including adults≥ 65 years of age, who
are at greater risk of influenza-related complications. In many countries, enhanced vaccines …

Background A number of cost-effectiveness analysis of influenza vaccination have been
conducted to estimate value of influenza vaccines in elderly and health workers (HWs). This …

Objectives Older adults are at high risk of influenza-related complications or hospitalization.
The purpose of this systematic review is to assess the relative cost-effectiveness of all …

Introduction Due to waning immunity, adults aged≥ 65 years are at increased risk of
seasonal influenza infection and its complications. Adding to this risk, older adults have …

Background: Evidence on influenza vaccine effectiveness (VE) in preventing mortality and
morbidity in the elderly is weak. Our aim was to measure the VE against severe outcomes in …